GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 707 filers reported holding GLAXOSMITHKLINE PLC in Q1 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $336,000 | 0.0% | 7,721 | 0.0% | 0.16% | +9.7% |
Q1 2022 | $336,000 | -12.5% | 7,721 | -11.5% | 0.14% | -2.7% |
Q4 2021 | $384,000 | +10.0% | 8,721 | -4.4% | 0.15% | +1.4% |
Q3 2021 | $349,000 | -9.8% | 9,121 | -6.2% | 0.15% | -9.3% |
Q2 2021 | $387,000 | -0.8% | 9,721 | -11.0% | 0.16% | -4.7% |
Q1 2021 | $390,000 | -12.0% | 10,921 | -9.2% | 0.17% | -16.7% |
Q4 2020 | $443,000 | -2.2% | 12,021 | 0.0% | 0.20% | -10.5% |
Q3 2020 | $453,000 | -7.6% | 12,021 | 0.0% | 0.23% | -11.6% |
Q2 2020 | $490,000 | +8.2% | 12,021 | +0.5% | 0.26% | -3.0% |
Q1 2020 | $453,000 | -19.4% | 11,965 | 0.0% | 0.27% | +0.4% |
Q4 2019 | $562,000 | +8.3% | 11,965 | -1.6% | 0.26% | +1.9% |
Q3 2019 | $519,000 | +5.5% | 12,165 | -1.1% | 0.26% | +4.0% |
Q2 2019 | $492,000 | -4.3% | 12,302 | 0.0% | 0.25% | -4.9% |
Q1 2019 | $514,000 | +9.4% | 12,302 | 0.0% | 0.26% | -1.5% |
Q4 2018 | $470,000 | -12.3% | 12,302 | -7.9% | 0.27% | -1.5% |
Q3 2018 | $536,000 | -0.6% | 13,362 | 0.0% | 0.27% | -10.3% |
Q2 2018 | $539,000 | +2.3% | 13,362 | -1.1% | 0.30% | +0.3% |
Q1 2018 | $527,000 | +6.0% | 13,512 | -3.6% | 0.30% | +10.7% |
Q4 2017 | $497,000 | -24.5% | 14,012 | -13.6% | 0.27% | -27.1% |
Q3 2017 | $658,000 | -7.6% | 16,212 | -1.8% | 0.37% | -10.6% |
Q2 2017 | $712,000 | +0.4% | 16,512 | -1.8% | 0.42% | -1.4% |
Q1 2017 | $709,000 | -23.8% | 16,812 | -21.7% | 0.42% | -26.4% |
Q4 2016 | $931,000 | +0.3% | 21,475 | -0.2% | 0.58% | -0.3% |
Q3 2016 | $928,000 | -0.3% | 21,512 | +0.2% | 0.58% | +0.3% |
Q2 2016 | $931,000 | +6.4% | 21,475 | -0.5% | 0.58% | +4.4% |
Q1 2016 | $875,000 | +34.6% | 21,575 | +33.8% | 0.55% | +28.4% |
Q4 2015 | $650,000 | +1.7% | 16,125 | -3.0% | 0.43% | -5.7% |
Q3 2015 | $639,000 | -7.9% | 16,625 | -0.3% | 0.46% | -1.9% |
Q2 2015 | $694,000 | -7.2% | 16,675 | +2.8% | 0.46% | -6.1% |
Q1 2015 | $748,000 | +7.8% | 16,225 | -0.1% | 0.49% | +9.1% |
Q4 2014 | $694,000 | -5.2% | 16,235 | +1.9% | 0.45% | -8.5% |
Q3 2014 | $732,000 | +14.2% | 15,935 | +33.0% | 0.50% | +21.6% |
Q2 2014 | $641,000 | -4.3% | 11,985 | -4.4% | 0.41% | -18.1% |
Q1 2014 | $670,000 | -1.8% | 12,535 | -1.8% | 0.50% | +10.4% |
Q4 2013 | $682,000 | – | 12,760 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |